Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cyclosporine Time in Therapeutic Range on Cellular Rejection After Heart Transplantation
TCTR20240319005Completed
- Sponsor
- N/A
- Start
- Mar 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Single-arm trial of cyclosporine in Cardiac Rejection, sponsored by N/A. Primary endpoint: Incidence of cellular rejection within 1 year after heart transplantation. Started Mar 2023; status: completed.
02
Drugs
cyclosporine
03
Conditions
Cardiac Rejection
Beyond the preview
Go deeper on TCTR20240319005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240319005.